$0.40
+0.02 (+6.09%)
Open$0.43
Previous Close$0.37
Day High$0.48
Day Low$0.38
52W High$10.33
52W Low$0.37
Volume—
Avg Volume124.9K
Market Cap7.60M
P/E Ratio—
EPS$-4.49
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+10,912.6% upside
Current
$0.40
$0.40
Target
$43.72
$43.72
$35.70
$43.72 avg
$58.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 37.43M | 4.18M | 3.97M |
| Net Income | -126,343,116 | -1,151,363 | -1,086,006 |
| Profit Margin | -16,993.3% | -27.6% | -27.4% |
| EBITDA | -126,568,707 | -1,394,086 | -1,159,340 |
| Free Cash Flow | — | -921,744 | -1,324,564 |
| Rev Growth | — | +11.5% | +10.2% |
| Debt/Equity | — | 0.72 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |